Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Apo-Diltiaz 30mg*


Contraindicated

Contraindicated
Apo-Diltiaz 30mg* :
Type Medicine Non Marketed
Originator G
Agent Promopharm
Distributor Promopharm
Laboratory Apotex
Responsible Party Apotex Inc
Origin Canada
Manufacturer Apotex Inc
Manufacturing Type G
Origin Canada
ATC C08DB01

Your comment will appear shortly after approval

Apo-Diltiaz 30mg* :

Revision Date : 30/11/2015


Effect Frequency
Acute generalised exanthematous pustulosis (AGEP) Not known
ALT increased Uncommon
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
AST increased Uncommon
Asthenia Common
Atrioventricular block (AVB) Common
Bradycardia Uncommon
Bundle branch block Common
Congestive heart failure Not known
Constipation Common
Depression Not known
Dermatitis exfoliative Not known
Diarrhoea (Diarrhea) Uncommon
Dry mouth (Xerostomia) Rare
Dyspepsia Common
Epigastralgia (Epigastric pain) Common
Erythema Common
Erythema multiforme Not known
Extrapyramidal symptoms Not known
First degree atrioventricular block Common
Flushing Common
Gingival hyperplasia Not known
Gynecomastia (Gynaecomastia) Not known
Headache Common
Hepatic enzyme increased Uncommon
Hepatitis Not known
Hyperglycaemia Not known
Insomnia Uncommon
LDH elevated Uncommon
Leukocytoclastic vasculitis Not known
Lichenoid keratosis Not known
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Malaise Common
Mood alteration Not known
Nausea Common
Nervousness Uncommon
Oedema of lower extremities Very Common
Orthostatic hypotension Uncommon
Palpitations Common
Phosphatase alkaline increased Uncommon
Photosensitivity reaction Not known
Second degree atrioventricular block Common
Sinoatrial block Not known
Skin rash Not known
Stevens-Johnson syndrome Not known
Sweating Not known
Third degree atrioventricular block Common
Thrombocytopenia (Thrombopenia) Not known
Urticaria Rare
Vasculitides Not known
Vertigo Common
Vomiting Uncommon

Different Units By MoH Code

Revision Date : 03/01/2018

Revision Date : 03/01/2018

Apo-Diltiaz 30mg*  MoH 3823 :
Form Tablet
Package Size Box of 100
Strength 30mg
Storage Condition 15-30°C protect from humidity & light
NSSF ✘
Quarantine ✘
Reg. Number 27354
Submission date 01/01/1992
Registration Year 1992
Archived Date 2014


Price Comparison

● Country: KSA
● Package Size: 30
● Public Price: 12.45 SAR ( 294,318.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,415 SAR ( 0.00 LBP )
● Reference: sfda
● Pricing Date: 05/03/2020
● Type: Medicine Non Marketed

● Country: Qatar
● Package Size: 100
● Public Price: 30 QAR ( 736,740.00 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,3 QAR ( 0.00 LBP )
● Pharmacy Price: 24.848240908829 QAR ( 610223.10023903 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info